Bell Investment Advisors’s Agilon Health AGL Stock Holding History

Bell Investment Advisors’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Buy	+2	New	+$1.22K	﹤0.01%	1312

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Bell Investment Advisors's AGL Position: Q4 2021 in Review

Bell Investment Advisors opened a new position in Agilon Health (AGL) in Q4 2021: 2 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1312 among its holdings.

132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.

Bell Investment Advisors held 2 shares of Agilon Health worth $1K as of Q4 2021.
Agilon Health was a new Bell Investment Advisors position in Q4 2021.
Agilon Health made up ﹤0.01% of Bell Investment Advisors's portfolio in Q4 2021, its #1312 holding.
132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.

Based on Bell Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.